Compare Shubhshree Bio. with Similar Stocks
Total Returns (Price + Dividend) 
Shubhshree Bio. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Is Shubhshree Bio. overvalued or undervalued?
As of 18 November 2025, Shubhshree Bio. has moved from an attractive to a very expensive valuation grade. The company is currently deemed overvalued based on its financial ratios, with a PE ratio of 25.31, an EV to EBITDA of 19.86, and a ROCE of 26.32%. When compared to peers, Waaree Energies has a higher PE ratio of 34.95, while Suzlon Energy has a lower PE of 24.38, indicating that Shubhshree Bio. is trading at a premium relative to some competitors. The company's stock performance has also been underwhelming recently, with a year-to-date return of -1.75%, contrasting sharply with the Sensex's gain of 9.58% over the same period. This further reinforces the notion that Shubhshree Bio. is currently overvalued in the market....
Read full news article Announcements 
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (0.11%)
Sagar Agrawal (24.47%)
Jinendra Kumar Jain (2.08%)
19.1%






